Short report: Clinical epidemiologic profile of a cohort of post-kala-azar dermal leishmaniasis patients in Bihar, India

American Journal of Tropical Medicine and Hygiene

Volumn 86, Issue 6, 2012, Pages 959-961

  Das, Vidya Nand Rabi ^a   Ranjan, Alok ^a   Pandey, Krishna ^a   Singh, Dharmendra ^a   Verma, Neena ^a   Das, Sushmita ^a   Lal, Chandra S ^a   Sinha, Naresh K ^a   Verma, Rakesh B ^a   Siddiqui, Niyamat A ^a   Das, Pradeep ^a  

^a RAJENDRA MEMORIAL RESEARCH INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIMONY GLUCONATE; MILTEFOSINE; PAROMOMYCIN; ANTIPROTOZOAL AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; FAMILY HISTORY; FEMALE; GENDER; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; PARASITE TRANSMISSION; POST KALA AZAR DERMAL LEISHMANIASIS; PRESCHOOL CHILD; SCHOOL CHILD; SKIN LEISHMANIASIS; TREATMENT DURATION; VISCERAL LEISHMANIASIS; DISEASE TRANSMISSION; INCIDENCE; MIDDLE AGED;

ADOLESCENT; ADULT; AMPHOTERICIN B; ANTIPROTOZOAL AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; INDIA; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84862224738     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2012.11-0467     Document Type: Article

References (16)

1. Zijlstra EE, Musa AM, Khalil EA, El-Hassan IM, El-Hassan AM, 2003. Post-kala-azar dermal leishmaniasis. Lancet Infect Dis 3: 87-98. (Pubitemid 36164205)
2. Ramesh V, Mukherjee A, 1995. Post kala-azar dermal leishmaniasis. Int J Dermatol 34: 85-91.
3. Zijlstra EE, El-Hassan AM, Ismail A, Ghalib HW, 1994. Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and sub-clinical infection and post kala-azar dermal leishmaniasis. Am J Trop Med Hyg 51: 826-836.
4. Manson-Bahr PE, Bell DR, 1987. Manson's Tropical Diseases. 19th edition. London: Bailliere Tindall/ELBS, 87-113.
5. World Health Organization, 1984. The leishmaniases. Report of the WHO Expert Committee. World Health Organ Tech Rep Ser 701: 1-140.
6. Sen Gupta PC, 1968. Leishmaniasis in India. J Med Assoc India 50: 34-36.
7. Addy M, Nandi A, 1992. Ten years of kala-azar in West Bengal. Part I. Did post-kala-azar dermal leishmaniasis initiate the outbreak in 24-Paraganas? Bull World Health Organ 70: 341-346.
8. Thakur CP, Kumar A, Mitra G, Thakur S, Sinha PK, Das P, Bhattacharya SK, Sinha AK, 2008. Impact of amphotericin B in the treatment of kala-azar on the incidence of PKDL in Bihar, India. Indian J Med Res 128: 38-44.
9. Thakur CP, Kumar K, 1992. Post kala-azar dermal leishmaniasis: a neglected aspect of kala-azar control programmes. Ann Trop Med Parasitol 86: 355-359.
10. Desjeux P, 2001. The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg 95: 239-243. (Pubitemid 33713068)
11. Dinesh DS, Kar SK, Kishore K, Palit A, Verma N, Gupta AK, Chauhan DS, Singh D, Sharma VD, Katoch VM, 2000. Screening sandflies for natural infection with Leishmania donovani using a non-radioactive probe based on the total DNA of the parasite. Ann Trop Med Parasitol 94: 447-451. (Pubitemid 30639127)
12. Salotra P, Singh R, 2006. Challenges in the diagnosis of post kalaazar dermal leishmaniasis. Indian J Med Res 123: 295-310. (Pubitemid 43905571)
13. ICDDRB, 2007. Post kala-azar dermal leishmaniasis: new observations challenge previous assumptions. Health Sci Bull 5: 6-12.
14. Brahmachari UN, 1992. A new form of cutaneous leishmaniasis, dermal leishmanoid. Ind Med Gaz 57: 125-127.
15. Thakur CP, Kumar M, Mishra BN, Pandey AK, 1988. Rationalization of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomized study. BMJ 296: 1557-1561.
16. World Health Organization, 1990. Control of leishmaniasis. World Health Organ Tech Rep Ser 739: 1-158.